Dolutegravir Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Dolutegravir Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22712
Buy Now

Dolutegravir Prices March 2023

Category Region Price
Dolutegravir Pharma API India 266,235 USD/MT

In Q1 2024, market pricing in India was driven by increased demand, positive market sentiment, and rising oil prices. Despite the obstacles, the market recovered with increased trade activity and regular output rates. Besides this, supply levels remained low, prompting merchants to sell inventory at high prices. This resulted in higher pricing, reflecting customer confidence and purchase activity. Aside from this, the festival season also led to price hikes. Moreover, quarter-end destocking actions had a further influence on pricing, resulting in a final price settlement of 266,235 USD/ MT, with a minor quarterly decline.

Dolutegravir Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Dolutegravir Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of dolutegravir pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of dolutegravir at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of dolutegravir price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing dolutegravir price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Dolutegravir Price Trend

Dolutegravir Market Analysis

The global dolutegravir market size reached US$ 5.2 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 8.1 Billion, at a projected CAGR of 5.00% during 2023-2032.

  • The market has experienced robust growth, driven by the rising prevalence of human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) worldwide, fueling the demand for effective antiretroviral therapies for viral suppression and improved patient outcomes.
  • In confluence with this, the escalating awareness about the benefits of early HIV diagnosis and treatment has led to higher adoption rates of dolutegravir-based regimens, creating a positive outlook for market expansion.
  • Moreover, the implementation of favorable government initiatives and funding support aimed at combating the HIV/AIDS epidemic have facilitated greater access to this medicine in developing countries, thereby bolstering the market growth.
  • The emergence of drug-resistant HIV strains necessitating the development and adoption of novel antiretroviral drugs like this, which exhibit a higher genetic barrier to resistance is acting as another significant growth-inducing factor.
  • Concurrent with this, significant advancements in pharmaceutical research and development (R&D) have resulted in the introduction of the formulation of this drug with improved efficacy, safety, and tolerability profiles, further strengthening the expanding market.
  • Strategic collaborations and partnerships between pharmaceutical companies and healthcare organizations facilitating the development, production, and distribution of this medicine are positively impacting the market growth.
  • Moreover, the growing demand for single-tablet regimens incorporating this pharmaceutical API has simplified treatment regimens and improved patient adherence, thereby aiding in market expansion.
  • In line with this, the increasing focus on healthcare infrastructure development and capacity building in emerging economies has improved access to dolutegravir-based therapies, influencing the market growth.
  • Furthermore, the introduction of favorable reimbursement policies and insurance coverage for HIV/AIDS treatment have incentivized patient compliance and contributed to the uptake of this medicine in both developed and developing markets, thereby fostering market expansion.
  • Apart from this, the growing emphasis on HIV prevention strategies such as pre-exposure prophylaxis (PrEP) spurring the demand for dolutegravir-based regimens for use in HIV prevention programs is presenting lucrative opportunities for market expansion.

Dolutegravir News

The report covers the latest developments, updates, and trends impacting the global dolutegravir market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in dolutegravir production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the dolutegravir price trend.

Latest developments in the dolutegravir industry:

  • In September 2023, ViiV Healthcare received tentative approval from the US FDA for a dispersible tablet formulation of abacavir, dolutegravir, and lamivudine for HIV-1 treatment in pediatric patients aged 3 months and above.
  • In April 2022, Qilu Pharmaceuticals approved its "dotegravir sodium tablet" application for listing, marking the first time a Chinese company has declared a generic drug for Dolutegravir, an anti-AIDS drug developed by GlaxoSmithKline/ViiV.

Product Description

Dolutegravir is an antiretroviral medicine used in conjunction with other treatments to treat HIV infection in adults and adolescents over the age of 12 who weigh at least 40 kg. It functions as an integrase inhibitor, preventing the virus from using the integrase enzyme to replicate itself within the body.

Owing to its high genetic resistance barrier, this drug functions as an integral part of HIV therapy regimens, particularly for patients who have not responded to previous treatment attempts. This drug is sold in tablet form for oral administration, with dose regimens dependent on the patient's age, weight, renal function, and current medicines. It is only available with a prescription, which should only be written by a medical professional skilled in treating HIV infection.

With its strong viral suppression, resistance to side effects, and safety features, this medication represents a major breakthrough in the treatment of HIV/AIDS, improving the prognosis and quality of life for those who suffer from this chronic illness.

Regional Coverage

The report provides a detailed analysis of the dolutegravir market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the dolutegravir price trend.

Global Dolutegravir Price

The report offers a holistic view of the global dolutegravir pricing trends in the form of dolutegravir price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of dolutegravir but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed dolutegravir demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Dolutegravir Price

During the first quarter, there were notable price swings in the European market, which were initially fueled by robust product demand. Prices did, however, decline as a result of excessive hoarding, weak demand in downstream industries, and diminished import opportunities. March saw lower production expenses due to lower freight charges and lower raw material prices. Unimproved purchase levels from downstream sectors, however, raised worries.

This analysis can be extended to include detailed dolutegravir price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Dolutegravir Price

The market in North America experienced fluctuation in Q1 2024, with prices rising as a result of higher demand. However, prices went up as a result of lower freight expenses and higher manufacturing costs. Prices fell in March as a consequence of excessive hoarding, sluggish demand in the downstream sectors, and dimmed import expectations. Because of the excess, exporting areas had to reduce their prices, underscoring the significance of maintaining competitiveness in an area with high import volumes.

Specific dolutegravir historical data within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada

Middle East and Africa Dolutegravir Price

The report explores the dolutegravir pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on dolutegravir prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Dolutegravir Price

The Asia Pacific market saw a spike in demand in Q1 2024, mostly due to foreign trade orders and robust downstream sector demand. Rising oil costs, however, presented difficulties and had an impact on profitability. In spite of this, the market saw improvement because of increased trade activity and steady production rates. Prices rose as a result of the shortage as supply levels remained low. The Festival Season and other seasonal circumstances also led to price increases.

This dolutegravir price analysis can be expanded to include a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Dolutegravir Price

The analysis of dolutegravir prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Report Coverage

Key Attributes Details
Product Name Dolutegravir
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Dolutegravir Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of dolutegravir pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting dolutegravir price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The dolutegravir price charts ensure our clients remain at the forefront of the industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Dolutegravir Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More